Company / Accounts Receivable
HealthEquity Accounts Receivable History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$123.7M
FY2026
5-year range
$87.4M / $123.7M
FY2022-FY2026
Trend
+0.0%
vs FY2025
Sector context
#86 of 138
Health Care
What the data says
At $124M, HealthEquity's accounts receivable ranks #86 of 138 in the Health Care sector. Improved from $118M to $124M over the past 2 years.
Based on SEC 10-K filings.
$124M in FY2026 with a 5-year CAGR of +11.2%.
Improved from $118M to $124M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +5.7%
- 5-Year CAGR
- +11.2%
- 10-Year CAGR
- -
Sector benchmark
#86 of 138 in Health CareTop 62% of 138This company $123.7M Sector average $1.3B
▼
-90.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +11.2%, indicating consistent growth.
- In FY2026, accounts receivable increased 0.0% year-over-year.
- Ranks #86 out of 138 companies in the Health Care sector.
- Lowest accounts receivable in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $123.7M | +0.0% |
| FY2025 | $123.7M | +4.8% |
| FY2024 | $118.0M | +12.5% |
| FY2023 | $104.9M | +20.0% |
| FY2022 | $87.4M | +20.1% |
| FY2021 | $72.8M | +0.0% |
| FY2020 | $72.8M | +2.7% |
| FY2019 | $70.9M | +176.1% |
| FY2018 | $25.7M | +18.8% |
| FY2017 | $21.6M | +27.1% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026